ReviewJournal of leukocyte biology2008
T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't.
Review in Journal of leukocyte biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 30 citations in OpenAlex.
- Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology.Journal of gastroenterology and hepatology · 2015Article
- Tolerance--is it worth it?Cold Spring Harbor perspectives in medicine · 2014Review
- Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Frontiers in immunology · 2014Review
- Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid.Journal of immunology (Baltimore, Md. : 1950) · 2013Article
- Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.PloS one · 2012Article
- Article
- NK cells, innate immunity and hepatitis C infection after liver transplantation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2011Review
- Th17 cells and their associated cytokines in liver diseases.Cellular & molecular immunology · 2010Review
- Viral vaccines and CTL response.Journal of biomedicine & biotechnology · 2010Review
- PD-1 tempers Tregs in chronic HCV infection.The Journal of clinical investigation · 2009Article
- Molecular and contextual markers of hepatitis C virus and drug abuse.Molecular diagnosis & therapy · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The mechanism behind the apparent lack of effective antiviral immune response in patients with chronic hepatitis C virus (HCV) infection is poorly understood. Although multiple levels of abnormalities have been identified in innate and adaptive immunity, it remains unclear if any of the subpopulations of T cells with regulatory capacity (Tregs) contribute to the induction and maintenance of HCV persistence. In this review, we summarize the current knowledge about Tregs as they relate to HCV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.